Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Acute Coronary Syndrome

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Acute Coronary Syndrome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mingate, MD; Nair, NK; Palur Ramakrishnan, AV; Vanapalli, S; Varghese, TP1

Reviews

1 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Acute Coronary Syndrome

ArticleYear
Platelet activating factor: A potential biomarker in acute coronary syndrome?
    Cardiovascular therapeutics, 2017, Volume: 35, Issue:1

    Topics: Acute Coronary Syndrome; Animals; Biomarkers; Blood Platelets; Humans; Inflammation Mediators; Platelet Activating Factor; Platelet Activation; Predictive Value of Tests; Prognosis; Signal Transduction

2017